Dr. Zivadinov testifying at Canadian Senate
Posted: Thu Nov 01, 2012 12:46 pm
http://www.buffalo.edu/news/13776
"While our research points against CCSVI having a primary causative role in the development of MS, we have established that there is a higher prevalence of CCSVI in progressive MS patients," said Zivadinov. "This suggests that CCSVI may contribute to, or be a consequence of disease progression, with important implications for treating its symptoms."
No role for endovascular treatment of CCSVI outside of approved clinical trials? My own jugulars were 99% and 80% blocked. Treatment was life-changing. I can't support Dr. Zivadinov's belief that there is no role for standard angioplasty on blocked blood vessels such as I had. Yes, do the clinical trials, but no, don't hold us back from seeking treatment."CCSVI intervention should be restricted to blinded, randomized and controlled clinical trials that will establish the safety and efficacy of these endovascular procedures," Zivadinov said. "This should be done according to established clinical, MRI (magnetic resonance imaging), and quality of life treatment outcomes employing safe and ethical approaches.
"Until these steps are accomplished, I believe there is no role for endovascular treatment of CCSVI in MS patients or in patients with other neurological disorders outside of approved clinical trials," he concluded.